Showing 9,738 results

Filters Content type: News, Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Coronavirus

Switzerland: HIV infections drop by a third

Editor's pick
Swiss Info
23 November 2020
Ethnic & cultural minorities

UK: Black people less likely to be engaged in HIV care, with more cases of viral rebound

News
23 November 2020
Experiences of stigma

Very poor knowledge of HIV among staff at major London hospitals

News
23 November 2020
Government, leadership & policy

NYC’s Leather Daddy HIV Czar Is Going to the CDC—And Advocates Nationwide Are Thrilled

Editor's pick
TheBody
20 November 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
HIV treatment for children & young people

WHO and other stakeholders join forces to accelerate access to effective paediatric HIV and tuberculosis diagnostics and medicines

Editor's pick
World Health Organization
20 November 2020
Ageing & HIV

How should we care for older people with HIV?

News
19 November 2020
Epidemiology

HIV death rate in South African men much higher than in women

Editor's pick
Spotlight
18 November 2020
HIV testing programmes & uptake

Almost half of HIV diagnoses in Europe are late, with serious impact on health outcomes

News
18 November 2020
Government, leadership & policy

As the Trump Era Ends, HIV Activists Need to Go Big or Go Home

Editor's pick
TheBody
17 November 2020
Injectable & long-acting PrEP

ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention

Editor's pick
ViiV press release
17 November 2020
Government, leadership & policy

Trump Administration Moves to Entrench Global Gag Rule

Editor's pick
Human Rights Watch
17 November 2020
Government, leadership & policy

Three Immediate Ways the Fight Against HIV Is Likely to Change in the Biden-Harris Administration

Editor's pick
TheBodyPro
16 November 2020
Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Improving HIV care

Escalate HIV Adherence Strategies Amid COVID-19

Editor's pick
Medscape (requires free registration)
16 November 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Improving HIV care

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

Editor's pick
TheBodyPro
11 November 2020
People & personal stories

IAS names Birgit Poniatowski as IAS Executive Director

Editor's pick
International AIDS Society
11 November 2020
Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services

News
11 November 2020
Clinical trials

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Editor's pick
FDA
10 November 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Drug policy & policing

Where the Biden Administration Will Stand on Drugs and Harm Reduction

Editor's pick
Filter
10 November 2020